Back to RIGL
Hennion & Walsh Asset Management, Inc. → RIGL
Hennion & Walsh Asset Management, Inc. RIGL Position History
Rigel Pharmaceuticals, Inc.
Quarters held
4
Latest value
$4.4M
Q3 2026
Peak value
$4.4M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $2.2M |
| Q1 2026 | $1.8M |
| Q2 2026 | $3.4M |
| Q3 2026 | $4.4M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $4.4M | 90.8K | — | — |
| Q2 2026 | $3.4M | 87.8K | — | — |
| Q1 2026 | $1.8M | 66.2K | — | — |
| Q4 2025 | $2.2M | 52.2K | — | — |
Other funds holding RIGL
$40.7M
$40.7M
$30.3M
$22.4M
$22.4M
$15.1M
$13.8M